Evaluation of primary and secondary responses to a T-cell-dependent antigen, keyhole limpet hemocyanin, in rats

Journal of Immunotoxicology

Volumn 10, Issue 1, 2013, Pages 40-48

  Kawai, Ryota ^a   Ito, Shiho ^a   Aida, Tetsuo ^a   Hattori, Hiroyuki ^a   Kimura, Tsutomu ^a   Furukawa, Tadashi ^a   Mori, Kazuhiko ^a   Sanbuissho, Atsushi ^a   Kawada, Teruo ^b  

^a DAIICHI SANKYO CO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

ELISA; KLH; PFC; Primary and secondary response; Rats; SRBC; TDAR

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE GHOST; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SHEEP ERYTHROCYTE;

ANIMALS; ANTIBODY FORMATION; FEMALE; HEMOCYANIN; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; RATS; RATS, INBRED F344; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84874311606     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2012.691122     Document Type: Article

References (23)

1. Bugelski, P. J., and Kim, C. 2007. T-Dependent antigen response (TDAR) Tests: Meta-analysis of results generated across multiple laboratories. J. Immunotoxicol. 4: 159-164.
2. Cunningham, A. J. 1965. A method of increased sensitivity for detecting single antibody-forming cells. Nature 207: 1106-1107.
3. Cunningham, A. J., and Szenberg, A. 1968. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14: 599-600.
4. Dodge, J. T., Mitchell, C., and Hanahan, D. J. 1963. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem.Biophys. 100: 119-130.
5. Finco-Kent, D., and Kawabata, T. T. 2005. Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation. J. Immunotoxicol. 2: 197-201.
6. Friedman, E. M., Becker, K. A., Overstreet, D. H., and Lawrence, D. A. 2002. Reduced primary antibody responses in a genetic animal model of depression. Psychosom. Med. 64: 267-273.
7. Gore, E R. 2006. Immune function tests for hazard identification: A paradigm shift in drug development. Basic Clin. Pharmacol. Toxicol. 98: 331-335.
8. Gore, E. R., Gower, J., Kurali, E., Sui, J. L., Bynum, J., Ennulat, D., and Herzyk, D. J. 2004. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Toxicology 197: 23-35.
9. Hanahan, D. J., and Ekholm, J. E. 1974. The preparation of red cell ghosts (membranes). Methods Enzymol. 31: 168-172.
10. Henry, M. L. 1999. Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles. Clin. Transplant. 13: 209-220.
11. Herzyk, D. J., and Holsapple, M. 2007. Immunotoxicity evaluation by immune function tests: Focus on the T-dependent antibody response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA]. J. Immunotoxicol. 4: 143-147.
12. ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) M3(R2) Guideline. 2009. Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals M3(R2).
13. ICH S8 Guideline. 2006. Immunotoxicity Studies for Human Pharmaceuticals S8.
14. Institoris, L., Siroki, O., Undeger, U., Basaran, N., and Desi, I. 2002. Immunotoxicological investigation in rats dosed repeatedly with combinations of cypermethrin, As(III), and Hg(II). Toxicology 172: 59-67.
15. Kawai, R., Nagayama, Y., Mori, K., and Kouchi, Y. 2010. The interlaboratory KLH-TDAR assay validation study II-investigation using an immunosuppressive agent. Proceedings of the 17th Annual Meeting of The Japanese Society of Immunotoxicology, Tsukuba-city in Japan, pp. 71-76.
16. Luster, M. I., Portier, C., Pait, D. G., White, K. L. Jr., Gennings, C., Munson, A. E., and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18: 200-210.
17. Piccotti, J. R., Alvey, J. D., Reindel, J. F., and Guzman, R. E. 2005. T-celldependent antibody response: Assay development in cynomolgus monkeys. J. Immunotoxicol. 2: 191-196.
18. Smialowicz, R. J., Riddle, M. M., Williams, W. C.-P. 1994. Species and strain comparisons of immunosuppression by 2-methoxyethanol and 2-methoxyacetic acid. Int. J. Immunopharmacol. 16: 695-702.
19. Smith, H. W., Winstead, C. J., Stank, K. K., Halstead, B. W., and Wierda, D. 2003. A predictive F344 rat immunotoxicology model: Cellular parameters combined with humoral response to NP-CγG and KLH. Toxicology 194: 129-145.
20. Stenzel-Poore, M. P., and Rittenberg, M. B. 1989. Clonal diversity, somatic mutation, and immune memory to phosphocholinekeyhole limpet hemocyanin. J. Immunol. 143: 4123-4133.
21. Temple, L., Kawabata, T. T., Munson, A. E., and White, K.L. Jr. 1993. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21: 412-419.
22. Ulrich, P., Paul, G., Perentes, E., Mahl, A., and Roman, D. 2004. Validation of immune function testing during a 4-week oral toxicity study with FK506. Toxicol. Lett. 149: 123-131.
23. White, K. L. Jr., Sheth, C. M., and Peachee, V. L. 2007. Comparison of primary immune responses to SRBC and KLH in rodents. J. Immunotoxicol. 4: 153-158.